Blood-Brain Barrier Transport Drugs Market Report

Global and Region Blood-Brain Barrier Transport Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：165
  • REPORT CODE：GMM998297
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Blood-Brain Barrier Transport Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Blood-Brain Barrier Transport Drugsmarket, defines the market attractiveness level of Blood-Brain Barrier Transport Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Blood-Brain Barrier Transport Drugs industry, describes the types of Blood-Brain Barrier Transport Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Blood-Brain Barrier Transport Drugs market and the development prospects and opportunities of Blood-Brain Barrier Transport Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Blood-Brain Barrier Transport Drugs market in Chapter 13.

    By Player:

    • BrainsGate

    • AZ Therapies

    • BioAdvance

    • Bach Pharma

    • Bioasis

    • EIP Pharma

    • Dainippon Sumitomo Pharma

    • NewGen Therapeutics

    • Minoryx

    • Palobiofarma

    • Fluorinov Pharma

    • Fondazione Telethon

    • Immune Pharmaceuticals

    • CarThera

    • Cyclenium

    By Type:

    • Carrier-mediated Transport

    • Receptor-mediated Transport

    • Absorptive-mediated Transport

    • Active Efflux Transport

    • Others

    By End-User:

    • Alzheimer's Disease

    • Epilepsy

    • Parkinson's Disease

    • Multiple Sclerosis

    • Hunter's Syndrome

    • Brain Cancer

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Blood-Brain Barrier Transport Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Blood-Brain Barrier Transport Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Blood-Brain Barrier Transport Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Blood-Brain Barrier Transport Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Blood-Brain Barrier Transport Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Blood-Brain Barrier Transport Drugs Consumption (2017-2022)

    • 7.2 United States Blood-Brain Barrier Transport Drugs Consumption (2017-2022)

    • 7.3 Europe Blood-Brain Barrier Transport Drugs Consumption (2017-2022)

    • 7.4 China Blood-Brain Barrier Transport Drugs Consumption (2017-2022)

    • 7.5 Japan Blood-Brain Barrier Transport Drugs Consumption (2017-2022)

    • 7.6 India Blood-Brain Barrier Transport Drugs Consumption (2017-2022)

    • 7.7 South Korea Blood-Brain Barrier Transport Drugs Consumption (2017-2022)

    8 Region and Country-wise Blood-Brain Barrier Transport Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Blood-Brain Barrier Transport Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Blood-Brain Barrier Transport Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Blood-Brain Barrier Transport Drugs Consumption Forecast (2022-2028)

    • 8.4 China Blood-Brain Barrier Transport Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Blood-Brain Barrier Transport Drugs Consumption Forecast (2022-2028)

    • 8.6 India Blood-Brain Barrier Transport Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Blood-Brain Barrier Transport Drugs Consumption Forecast (2022-2028)

    9 Global Blood-Brain Barrier Transport Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Blood-Brain Barrier Transport Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Carrier-mediated Transport Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Receptor-mediated Transport Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Absorptive-mediated Transport Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Active Efflux Transport Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Blood-Brain Barrier Transport Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Epilepsy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Parkinson's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Hunter's Syndrome Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Brain Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Blood-Brain Barrier Transport Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Blood-Brain Barrier Transport Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Carrier-mediated Transport Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Receptor-mediated Transport Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Absorptive-mediated Transport Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Active Efflux Transport Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Blood-Brain Barrier Transport Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Hunter's Syndrome Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Blood-Brain Barrier Transport Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Blood-Brain Barrier Transport Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Blood-Brain Barrier Transport Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Blood-Brain Barrier Transport Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Blood-Brain Barrier Transport Drugs Market Competitive Analysis

    • 14.1 BrainsGate

      • 14.1.1 BrainsGate Company Details

      • 14.1.2 BrainsGate Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 BrainsGate Blood-Brain Barrier Transport Drugs Product and Service

    • 14.2 AZ Therapies

      • 14.2.1 AZ Therapies Company Details

      • 14.2.2 AZ Therapies Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 AZ Therapies Blood-Brain Barrier Transport Drugs Product and Service

    • 14.3 BioAdvance

      • 14.3.1 BioAdvance Company Details

      • 14.3.2 BioAdvance Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 BioAdvance Blood-Brain Barrier Transport Drugs Product and Service

    • 14.4 Bach Pharma

      • 14.4.1 Bach Pharma Company Details

      • 14.4.2 Bach Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bach Pharma Blood-Brain Barrier Transport Drugs Product and Service

    • 14.5 Bioasis

      • 14.5.1 Bioasis Company Details

      • 14.5.2 Bioasis Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bioasis Blood-Brain Barrier Transport Drugs Product and Service

    • 14.6 EIP Pharma

      • 14.6.1 EIP Pharma Company Details

      • 14.6.2 EIP Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 EIP Pharma Blood-Brain Barrier Transport Drugs Product and Service

    • 14.7 Dainippon Sumitomo Pharma

      • 14.7.1 Dainippon Sumitomo Pharma Company Details

      • 14.7.2 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Product and Service

    • 14.8 NewGen Therapeutics

      • 14.8.1 NewGen Therapeutics Company Details

      • 14.8.2 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Product and Service

    • 14.9 Minoryx

      • 14.9.1 Minoryx Company Details

      • 14.9.2 Minoryx Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Minoryx Blood-Brain Barrier Transport Drugs Product and Service

    • 14.10 Palobiofarma

      • 14.10.1 Palobiofarma Company Details

      • 14.10.2 Palobiofarma Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Palobiofarma Blood-Brain Barrier Transport Drugs Product and Service

    • 14.11 Fluorinov Pharma

      • 14.11.1 Fluorinov Pharma Company Details

      • 14.11.2 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Product and Service

    • 14.12 Fondazione Telethon

      • 14.12.1 Fondazione Telethon Company Details

      • 14.12.2 Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Fondazione Telethon Blood-Brain Barrier Transport Drugs Product and Service

    • 14.13 Immune Pharmaceuticals

      • 14.13.1 Immune Pharmaceuticals Company Details

      • 14.13.2 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Product and Service

    • 14.14 CarThera

      • 14.14.1 CarThera Company Details

      • 14.14.2 CarThera Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 CarThera Blood-Brain Barrier Transport Drugs Product and Service

    • 14.15 Cyclenium

      • 14.15.1 Cyclenium Company Details

      • 14.15.2 Cyclenium Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Cyclenium Blood-Brain Barrier Transport Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Blood-Brain Barrier Transport Drugs

    • Figure Blood-Brain Barrier Transport Drugs Picture

    • Table Global Blood-Brain Barrier Transport Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Blood-Brain Barrier Transport Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Blood-Brain Barrier Transport Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Blood-Brain Barrier Transport Drugs Consumption by Country (2017-2022)

    • Figure United States Blood-Brain Barrier Transport Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Blood-Brain Barrier Transport Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Blood-Brain Barrier Transport Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Blood-Brain Barrier Transport Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Blood-Brain Barrier Transport Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Blood-Brain Barrier Transport Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Blood-Brain Barrier Transport Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Blood-Brain Barrier Transport Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Blood-Brain Barrier Transport Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Blood-Brain Barrier Transport Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Blood-Brain Barrier Transport Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Blood-Brain Barrier Transport Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Blood-Brain Barrier Transport Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Carrier-mediated Transport Consumption and Growth Rate (2017-2022)

    • Figure Global Receptor-mediated Transport Consumption and Growth Rate (2017-2022)

    • Figure Global Absorptive-mediated Transport Consumption and Growth Rate (2017-2022)

    • Figure Global Active Efflux Transport Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Epilepsy Consumption and Growth Rate (2017-2022)

    • Figure Global Parkinson's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)

    • Figure Global Hunter's Syndrome Consumption and Growth Rate (2017-2022)

    • Figure Global Brain Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Carrier-mediated Transport Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Receptor-mediated Transport Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Absorptive-mediated Transport Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Active Efflux Transport Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hunter's Syndrome Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Blood-Brain Barrier Transport Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Blood-Brain Barrier Transport Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table BrainsGate (Foundation Year, Company Profile and etc.)

    • Table BrainsGate Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table BrainsGate Blood-Brain Barrier Transport Drugs Product and Service

    • Table AZ Therapies (Foundation Year, Company Profile and etc.)

    • Table AZ Therapies Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AZ Therapies Blood-Brain Barrier Transport Drugs Product and Service

    • Table BioAdvance (Foundation Year, Company Profile and etc.)

    • Table BioAdvance Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioAdvance Blood-Brain Barrier Transport Drugs Product and Service

    • Table Bach Pharma (Foundation Year, Company Profile and etc.)

    • Table Bach Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bach Pharma Blood-Brain Barrier Transport Drugs Product and Service

    • Table Bioasis (Foundation Year, Company Profile and etc.)

    • Table Bioasis Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bioasis Blood-Brain Barrier Transport Drugs Product and Service

    • Table EIP Pharma (Foundation Year, Company Profile and etc.)

    • Table EIP Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table EIP Pharma Blood-Brain Barrier Transport Drugs Product and Service

    • Table Dainippon Sumitomo Pharma (Foundation Year, Company Profile and etc.)

    • Table Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Product and Service

    • Table NewGen Therapeutics (Foundation Year, Company Profile and etc.)

    • Table NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table NewGen Therapeutics Blood-Brain Barrier Transport Drugs Product and Service

    • Table Minoryx (Foundation Year, Company Profile and etc.)

    • Table Minoryx Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Minoryx Blood-Brain Barrier Transport Drugs Product and Service

    • Table Palobiofarma (Foundation Year, Company Profile and etc.)

    • Table Palobiofarma Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Palobiofarma Blood-Brain Barrier Transport Drugs Product and Service

    • Table Fluorinov Pharma (Foundation Year, Company Profile and etc.)

    • Table Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fluorinov Pharma Blood-Brain Barrier Transport Drugs Product and Service

    • Table Fondazione Telethon (Foundation Year, Company Profile and etc.)

    • Table Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fondazione Telethon Blood-Brain Barrier Transport Drugs Product and Service

    • Table Immune Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Product and Service

    • Table CarThera (Foundation Year, Company Profile and etc.)

    • Table CarThera Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table CarThera Blood-Brain Barrier Transport Drugs Product and Service

    • Table Cyclenium (Foundation Year, Company Profile and etc.)

    • Table Cyclenium Blood-Brain Barrier Transport Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cyclenium Blood-Brain Barrier Transport Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US